Haifa, Israel

Etan Saba

This inventor holds 1 USPTO granted patent. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Etan Saba

Introduction

Etan Saba is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of medical technology, particularly in cardiac procedures. His innovative work focuses on improving the accuracy and effectiveness of heart ablation techniques.

Latest Patents

Etan Saba holds a patent for a device known as the Pulmonary Vein Isolation Gap Finder. This invention addresses a critical issue in cardiac ablation by identifying gaps between ablation sites that can hinder electrical propagation in the heart. The device utilizes a 3-dimensional coordinate system to project the locations of ablation sites onto a simulation plane. It identifies the shortest 3-dimensional paths that correspond to 2-dimensional connections between pairs of these projected locations, ultimately reporting the longest gap as a significant finding.

Career Highlights

Etan Saba is currently employed at Biosense Webster (Israel) Ltd., a company renowned for its advancements in electrophysiology and cardiac mapping technologies. His work at this organization has allowed him to contribute to groundbreaking innovations in the medical field.

Collaborations

Throughout his career, Etan has collaborated with esteemed colleagues, including Meir Bar-Tal and David Izraeli. These partnerships have fostered a creative environment that encourages the development of new technologies and solutions in cardiac care.

Conclusion

Etan Saba's contributions to medical technology, particularly through his patent for the Pulmonary Vein Isolation Gap Finder, highlight his commitment to improving cardiac procedures. His work continues to influence the field and enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…